Xunda Pharmaceutical

About:

Hubei Xunda Pharmaceutical is a producer of anti-inflammatory and analgesic drugs, and bulk pharmaceutical chemicals for antibiotics.

Website: http://www.xundapharm.com

Top Investors: Shenzhen Capital Group

Description:

Hubei Xunda Pharmaceutical Co., Ltd. (迅达药业) is a modern Chinese pharmaceutical enterprise that produces anti-inflammatory and analgesic drugs, and bulk pharmaceutical chemicals for antibiotics and pharmaceutical intermediates. Hubei Xunda Pharmaceutical’s main product portfolio includes ketoprofen, felbinac, fosfomycin calcium, fosfomycin sodium, fosfomycin trometamol, cyano ketone ibuprofen, loxoprofen sodium, and more. These products have been sold to countries and regions such as Japan, Korea, the Middle East, Europe, and America. The company owns advanced production equipment, complete testing equipment, technical forces, scientific and standard management solutions, and a number of invention patents. Hubei Xunda Pharmaceutical has gotten through the Chinese GMP certification and official GMP on-site audit of JMHW, while its ketoprofen product has obtained the European COS certificate.